Mergers and Acquisitions

The partial sale of TikTok to Oracle, if it goes through, may be the final transaction of real substance in the career Oracle founder Larry Ellison.
Digital real estate firm Opendoor announced Tuesday that it will become a publicly traded company through a reverse merger with a blank-check company.
Immunomedics shares more than doubled on Monday after the firm announced that it would be acquired by Gilead Sciences in one of the biggest deals to go down in the health care sector this year.
Chipmaker Nvidia has reached an agreement with SoftBank to acquire chip designer Arm from the Japanese firm in a deal valued at $40 billion. Now comes the hard part.
Kansas City Southern stock is now close to an all-time high, but that may be due to reports of private equity buyout interest rather than that just the massive stock market recovery since March.
Tiffany's acquisition by French luxury goods firm LVMH is in danger of being canceled due to a dispute between the United States and the European Union over tariffs on certain luxury goods.
Investment firm Elliott Management has taken a position of unspecified size in Noble Energy. Chevron has agreed to acquire Noble in an all-stock deal valued at around $5 billion. What is Paul Singer...
Oilfield services firm Schlumberger is giving its North American fracking business to Liberty Oilfield Services in exchange for a piece of the combined business.
The prize for Nestle in its acquisition of Aimmune Therapeutics is Palforzia, the world’s first treatment for a food allergy.
Akcea Therapeutics stock jumped on Monday after it was announced that Ionis Pharmaceuticals would be acquiring all of its outstanding shares.
Consumer products giant Nestlé has agreed to acquire Aimmune Therapeutics, maker of a peanut-allergy treatment. The deal is valued at $2.6 billion, including Nestlé's existing stake Aimmune.
Trump administration fickleness may be the reason TikTok is not sold. That means a positive outcome for the video-sharing network in the United States is still in question.
The sale of TikTok has been highly contested, and Microsoft may have gained an edge in this fight, or at least one analyst thinks so.
Cancer Genetics shares more than doubled on Monday after the company announced a merger with StemoniX.
After Momenta Pharmaceuticals announced that it would be acquired by pharmaceutical giant Johnson & Johnson, the biotechnology company's shares soared on Wednesday.